节点文献
芒果苷在Caco-2细胞模型中转运机制的研究
Transport Mechanism of Mangiferin in Caco-2 Cell Model
【摘要】 目的 采用人结肠癌上皮细胞单层模型(Caco-2 细胞模型)研究芒果苷在小肠吸收转运的特性,探讨芒果苷的口服吸收机制。方法 采用 Caco-2 细胞模型进行芒果苷的跨膜转运实验,探讨时间、pH 值、浓度、外排转运蛋白 P-糖蛋白(P-gp)抑制剂、多药耐药相关蛋白 2(MRP2)抑制剂、乳腺癌耐药蛋白(BCRP)抑制剂对芒果苷转运的影响。结果 芒果苷在 Caco-2 细胞模型上的转运具有时间依赖性,不同浓度芒果苷在 Caco-2 细胞的表观渗透系数(Papp)无显著性差异,微绒毛面顶侧(AP)到底侧(BL)的 Papp(AP→BL)为(8.33±1.99)×10-6~(8.48±1.15)×10-6cm·s-1,BL 侧到 AP 侧的 Papp(BL→AP)为(29.19±3.64)×10-6~(33.20±5.72)×10-6cm·s-1,Papp(BL→AP)明显大于Papp(AP→BL)(P<0.05),药物外排率(ER)大于 3;芒果苷的 Papp随 pH 的增加而显著性增加;P-gp 抑制剂维拉帕米(P<0.001)和环孢素 A(P<0.05)能显著增加芒果苷 AP→BL 方向的表观渗透系数;MRP2 抑制剂 MK571 显著减少芒果苷两侧表观渗透系数(P<0.01);BCRP 抑制剂白杨素和烟曲霉素 C 对芒果苷的转运无明显影响。结论 芒果苷为中等吸收药物,碱性环境有利于其转运,在 Caco-2 细胞模型上的转运方式以被动扩散为主,并存在主动转运,不受外排蛋白 BCRP 的影响,但与 P-gp 有关,MK571 与芒果苷可能存在竞争转运。
【Abstract】 Objective To investigate the transport characteristics of mangiferin in Caco-2 cell model and to clarify the oral absorption mechanism of mangiferin. Methods Effects of time,pH,concentration,P-gp inhibitor,MRP2inhibitor,and BCRP inhibitor on the transportation of mangiferin in Caco-2 cell model were investigated. Results The transport of mangiferin in Caco-2 cell model was time dependent but Pappof mangiferin showed no difference in concentration,Papp(AP→BL)was(8.33±1.99)×10-6cm·s-1to(8.48±1.15)×10-6cm·s-1and Papp(BL→AP)was(29.19±3.64)×10-6cm·s-1to(33.20±5.72)×10-6cm·s-1;Papp(BL→AP)was significant higher than Papp(AP→BL)(P<0.05)and ER was more than 3. The Pappof mangiferin increased significantly with the increase of pH. P-gp inhibitors,verapamil(P<0.001)and cyclosporine A(P<0.05) obviously increased the Papp(AP→BL)of mangiferin. MRP2 inhibitor MK571 decreased bidirectional Pappof mangiferin markedly(P<0.01). BCRP inhibitor chrysin and Fumitremorgin C had no effect on Pappof mangiferin. Conclusion Mangiferin was well absorbed and alkaline environment was favorable for its transport. Passive diffusion was the main absorption mechanism of mangiferin and a cellular efflux system was participated. P- gp would influence the transport of mangiferin while BCRP not MK571 and mangiferin may have competitive translocation.
【Key words】 mangiferin; Caco-2 cell; transport; P-gp; MRP2;
- 【文献出处】 中药新药与临床药理 ,Traditional Chinese Drug Research and Clinical Pharmacology , 编辑部邮箱 ,2022年09期
- 【分类号】R285
- 【下载频次】369